clomipramine has been researched along with Stammering in 5 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clomipramine, a serotonin reuptake blocker that has been shown to be effective in treating obsessive-compulsive disorder and other unwanted repetitive, ritualized behaviors, was hypothesized to be superior to desipramine, a tricyclic antidepressant with selective noradrenergic effects, for developmental stuttering." | 9.08 | A double-blind comparison of clomipramine and desipramine in the treatment of developmental stuttering. ( Cotelingam, GM; Gordon, CT; Hamburger, SD; Ludlow, CL; Rapoport, JL; Stager, S, 1995) |
| "This study compared fluency changes in adult developmental stuttering speakers treated with two tricyclic antidepressants, clomipramine and desipramine." | 5.08 | Fluency changes in persons who stutter following a double blind trial of clomipramine and desipramine. ( Cotelingam, M; Gordon, CT; Ludlow, CL; Rapoport, JL; Stager, SV, 1995) |
| "Clomipramine, a serotonin reuptake blocker that has been shown to be effective in treating obsessive-compulsive disorder and other unwanted repetitive, ritualized behaviors, was hypothesized to be superior to desipramine, a tricyclic antidepressant with selective noradrenergic effects, for developmental stuttering." | 5.08 | A double-blind comparison of clomipramine and desipramine in the treatment of developmental stuttering. ( Cotelingam, GM; Gordon, CT; Hamburger, SD; Ludlow, CL; Rapoport, JL; Stager, S, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horga, G | 1 |
| Horga, A | 1 |
| Baeza, I | 1 |
| Castro-Fornieles, J | 1 |
| Lázaro, L | 1 |
| Pons, A | 1 |
| Stager, SV | 1 |
| Ludlow, CL | 2 |
| Gordon, CT | 2 |
| Cotelingam, M | 1 |
| Rapoport, JL | 2 |
| Cotelingam, GM | 1 |
| Stager, S | 1 |
| Hamburger, SD | 1 |
| Brady, JP | 1 |
| Ali, Z | 1 |
| Costa, D | 1 |
2 trials available for clomipramine and Stammering
| Article | Year |
|---|---|
Fluency changes in persons who stutter following a double blind trial of clomipramine and desipramine.
Topics: Adolescent; Adult; Clomipramine; Cross-Over Studies; Desipramine; Double-Blind Method; Female; Human | 1995 |
A double-blind comparison of clomipramine and desipramine in the treatment of developmental stuttering.
Topics: Adolescent; Adult; Attitude to Health; Clomipramine; Cross-Over Studies; Desipramine; Double-Blind M | 1995 |
3 other studies available for clomipramine and Stammering
| Article | Year |
|---|---|
Drug-induced speech dysfluency and myoclonus preceding generalized tonic-clonic seizures in an adolescent male with schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Clomipramine; Clozapine; Epilepsy, Tonic-Clonic; Humans; Male; Myo | 2010 |
Alprazolam, citalopram, and clomipramine for stuttering.
Topics: Alprazolam; Anti-Anxiety Agents; Citalopram; Clomipramine; Drug Therapy, Combination; Humans; Male; | 2000 |
Antidepressants and the treatment of stuttering.
Topics: Antidepressive Agents; Clomipramine; Fluoxetine; Humans; Mianserin; Stuttering | 1992 |